Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers

Clinical trial NCT03013881 · COMPLETED

Trial details

NCT number
NCT03013881
Sponsor
United BioPharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Neoplasm
Start date
2018-03-05
Primary completion
2018-10-08
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.